Pfizer COVID-19 vaccine appointments are available to our patients. Sign up for Connect today to schedule your vaccination. Review the latest on COVID-19 vaccines.
Entrepreneurship and innovation enable Weill Cornell Medicine to bring discoveries to patients faster.

Weill Cornell Medicine investigators enjoy a robust pipeline of dedicated programs capable of taking early discoveries made in academic labs to U.S. Food and Drug Administration-approved testing in clinical trials. Other new initiatives are designed to foster a culture of entrepreneurship and to build the next generation of leaders in life sciences industries and new ventures. 


Dean’s Symposium on Entrepreneurship and Academic Drug Development Spotlights Environment of Innovation, Collaboration at Weill Cornell Medicine

Dr. Jyotishman Pathak is a researcher who jokingly says that he’s “still learning to fake business” after launching a new company in 2019. New to the business world, he’s already a success.

Digital Domains: Apps, Video Games and Other Media are Filling Gaps in Mental Healthcare

Apps, video games and other media are filling gaps in mental healthcare.

Biomedical Business Plan Challenge Nurtures Weill Cornell Medicine Entrepreneurs

The culmination of a nine-week mentoring program that is designed to improve the ability of Weill Cornell Medicine clinicians and researchers to commercialize their concepts.

Diverse Teams Converge to Solve Healthcare Problems at Weekend Hackathon

The 3rd annual NYC Hackathon brought together nearly 200 students and faculty members from Weill Cornell Medicine, Cornell’s Ithaca campus, and several local and national academic institutions.
Views on Innovation
Dr. Augustine M.K. Choi, the Stephen and Suzanne Weiss Dean
We have recently implemented many initiatives to help our faculty translate their research findings into innovative treatments and therapies for our patients.
Dr. Katherine Hajjar, Senior Associate Dean of Faculty
Support from the Daedalus Fund for Innovation is essential, because the usual funding agencies do not support this kind of high-risk applied research.
Dr. William Povino, CEO of Bridge Medicines
Tri-Institutional Therapeutics Discovery Institute and Bridge Medicines put the skill of a pharmaceutical company on the campuses of three great institutions.
Larry Schlossman, Managing Director of BioPharma Alliances and Research Collaborations
We have a fully integrated entrepreneurship ecosystem here. And we really work as a team to help faculty decide what is the best path forward for their project.